Horst & Graben Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Buy
2,962
+398
+16% +$46.6K 0.05% 144
2026
Q1
$283K Buy
2,564
+188
+8% +$21.7K 0.04% 158
2025
Q4
$250K Buy
+2,376
New +$223K 0.04% 158
2025
Q1
Sell
-2,060
Closed -$205K 166
2024
Q4
$205K Buy
2,060
+13
+0.6% +$1.34K 0.04% 150
2024
Q3
$232K Buy
2,047
+11
+0.5% +$1.31K 0.04% 139
2024
Q2
$252K Buy
2,036
+9
+0.4% +$1.16K 0.05% 126
2024
Q1
$267K Sell
2,027
-9
-0.4% -$1.11K 0.05% 119
2023
Q4
$222K Sell
2,036
-938
-32% -$97.4K 0.05% 125
2023
Q3
$306K Buy
2,974
+498
+20% +$53.7K 0.08% 105
2023
Q2
$286K Buy
2,476
+16
+0.7% +$1.82K 0.07% 102
2023
Q1
$262K Buy
2,460
+15
+0.6% +$1.62K 0.07% 108
2022
Q4
$271K Buy
2,445
+19
+0.8% +$1.94K 0.07% 110
2022
Q3
$209K Buy
2,426
+18
+0.7% +$1.61K 0.06% 118
2022
Q2
$220K Buy
+2,408
New +$213K 0.06% 121

Other funds holding MRK

Horst & Graben Wealth Management's MRK Position: Q2 2026 in Review

Horst & Graben Wealth Management increased its Merck (MRK) stake by 16% in Q2 2026, buying an estimated $46.6K and bringing the position to 2,962 shares worth $371K. The position accounts for 0.05% of the portfolio, ranked #144.

Horst & Graben Wealth Management first reported a position in MRK in Q2 2022 and has held it in 14 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Horst & Graben Wealth Management held 2,962 shares of Merck worth $371K as of Q2 2026.
  • Horst & Graben Wealth Management bought 398 Merck shares in Q2 2026, an estimated $46.6K.
  • Merck made up 0.05% of Horst & Graben Wealth Management's portfolio in Q2 2026, its #144 holding.
  • Horst & Graben Wealth Management first reported a position in Merck in Q2 2022 and has held it in 14 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Horst & Graben Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.